Is stem cell therapy legal in the United States?
Yes, with important nuances. Certain MSC (mesenchymal stem cell) therapies are legally available in the US under state medical practice laws, particularly for orthopedic and pain-related conditions. Florida, Texas, and Utah have specific statutes allowing licensed physicians to offer certain unapproved cell procedures with strict documentation and informed consent requirements. For systemic protocols (IV infusion for anti-aging, autoimmune, or neurological conditions), Decima coordinates treatment at international clinics in Japan, the Cayman Islands, and Europe, where patients have the legal right to seek care. Every patient receives a clear written explanation of the regulatory status of their specific treatment before making any decision.
Is Decima a stem cell clinic?
No. Decima is a coordination and oversight platform. We do not administer treatments ourselves — we coordinate access to vetted clinics and physicians in our network, design your protocol, verify your cell sourcing, and manage your follow-up. This model allows us to always recommend the best clinic for your specific condition globally, not just the one we operate. Think of us as the medical equivalent of a trusted concierge who has already vetted every option.
How is Decima different from other stem cell providers?
Most stem cell providers are clinics that administer treatment. Their incentive is to treat you, regardless of whether you are the right candidate. Decima's incentive is different: we get paid for coordination, not for treatment volume. This means we will tell you honestly if you are not a strong candidate. We also independently verify cell quality (most clinics use the manufacturer's own testing), require third-party GMP certification for every product, and track your biomarkers at 30, 60, and 90 days post-treatment. No other stem cell service in the US does all three of these things for every patient.
What does the free assessment actually involve?
You complete a 10-question intake form covering your health history, current conditions, medications, and goals. This takes approximately 3 minutes. A board-certified Decima physician reviews your intake personally within 48 hours and contacts you directly by phone or secure message. There is no commitment, no deposit, and no sales pitch during this call. It is a genuine medical conversation about whether you are a candidate and what outcomes are realistic for your situation.
How much does treatment cost?
Orthopedic protocols (joint restoration) start at $5,000. GLP-1 recovery protocols start at $8,000. Hormonal recalibration starts at $12,000. Systemic anti-aging and neurological protocols start at $15,000–18,000. Autoimmune reset protocols start at $20,000. These are starting prices — your physician will provide a complete cost breakdown specific to your protocol before you commit to anything. A $500 deposit holds your treatment date. All treatment costs are paid out of pocket; insurance does not cover investigational stem cell therapy.
Do you treat patients outside the United States?
Yes. We coordinate treatment for patients globally. For European patients, we work with accredited clinics in Germany and Switzerland. For patients in the Middle East and Asia, we coordinate through our Japan and Cayman Islands network. All international patients receive the same physician review, protocol design, and post-treatment follow-up tracking as US patients. We can typically arrange international treatment within 4–6 weeks of completing the assessment.
What cells do you use and where do they come from?
Decima uses two primary cell types: Wharton's Jelly MSCs (mesenchymal stem cells derived from ethically donated umbilical cord tissue) and MUSE cells (Multilineage-Stressing Undifferentiated Stem Cells developed at Tohoku University, Japan). All cells are sourced from GMP-certified facilities and independently tested for viability (>85% required), sterility, identity, and endotoxin levels before every treatment. We provide the lab certificate to every patient before treatment day.
What happens after treatment?
Your physician schedules biomarker follow-up panels at 30, 60, and 90 days post-treatment. These panels track inflammatory markers, protocol-specific indicators, and cellular aging markers relevant to your treatment. Your physician reviews the results and contacts you with an interpretation. If results are not tracking as expected, they discuss protocol adjustments. Most patients have at least three physician touchpoints in the 90 days following treatment. We do not disappear after treatment day.
Are there patients who should not pursue stem cell therapy?
Yes. Stem cell therapy is not appropriate for everyone. Patients with active malignancy are generally not candidates. Patients with certain autoimmune conditions require careful sequencing before any cell therapy. Patients in acute inflammatory states may need preparation protocols before cells are introduced. Patients with very advanced degenerative conditions may have more realistic outcomes from surgical intervention. Our physicians are trained to identify these cases and will tell you directly if stem cell therapy is not the right path for you.
Is my medical information kept private?
All patient information is handled in accordance with HIPAA and applicable international privacy law. We do not share patient data with third parties, including partner clinics, without explicit written consent. Your intake, medical history, protocol, and biomarker results are confidential. Patients who participate in any research or outcomes tracking program are asked for separate written consent before any data is used.